Report Code : CVMI2603252601436 | Published Date : March 30, 2025
1 | Market Overview
The global market for chronic kidney disease (CKD) is experiencing significant growth, driven by the increasing rates of diabetes, hypertension, and aging populations. CKD is a progressive disease marked by the gradual decline of kidney function, which can lead to complications such as cardiovascular disease and end-stage renal disease (ESRD). Growing awareness, advances in diagnostic techniques, and the expansion of dialysis and transplant services are boosting demand.
Pharmaceutical innovation targeting CKD progression and its complications, along with government-led initiatives for early screening, further support market growth.
2 | Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
63.2 |
Historical benchmark |
2024 |
86.5 |
Five-year CAGR 6.5% |
2031 |
142.8 |
Seven-year CAGR 7.4% |
3 | Key Market Drivers
- Rising prevalence of diabetes and hypertension.
- Aging global population.
- Expanded access to dialysis and transplant services.
- Government-Led Awareness and Screening Programs.
- Development of Novel Therapeutics for CKD and Complications.
4 | Market Challenges
- High treatment costs.
- Late diagnosis in many patients.
- Limited Access to Advanced Care in Low-Income Countries.
- Side Effects of Long-Term Dialysis and Medication.
5 | Competitive Landscape
Company |
Estimated Market Share |
Key Products |
Baxter International |
20% |
Dialysis equipment and solutions |
Fresenius Medical Care |
18% |
Hemodialysis systems, peritoneal dialysis |
AbbVie |
14% |
CKD therapeutics (e.g., for anemia) |
AstraZeneca |
12% |
CKD medications including SGLT2 inhibitors |
Others |
36% |
Generic and specialty providers |
6 | Market Segmentation
By Treatment Type:
- Dialysis (Hemodialysis, Peritoneal Dialysis)
- Transplant
- Pharmacological Therapies
By Stage:
- Stage 1–2
- Stage 3–4
- Stage 5 (ESRD)
By End User:
- Hospitals
- Dialysis Centers
- Specialty Clinics
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
7 | Strategic Outlook
The CKD market is expected to continue expanding with earlier detection, advances in tele-nephrology, and personalised medicine approaches. Collaborations between pharmaceutical companies, device manufacturers, and healthcare systems will be crucial for improving patient outcomes.
Reasons To Buy

Scope

Key Players
- AstraZeneca
- Bayer
- Boehringer Ingelheim
- Johnson & Johnson
- GSK
- Novartis
- Fresenius Medical Care
- Baxter
Global Chronic Kidney Disease Market Report
- 1. Global Chronic Kidney Disease Market Research Report
- 1.1 Study Objectives
- 1.2 Global Chronic Kidney Disease Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Chronic Kidney Disease Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Treatment
- 2.1.2 By Drug Type
- 2.1.3 By End-User
- 2.1.4 By Distribution Channel
- 2.1.5 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Treatment, By Drug Type, By End-User, By Distribution Channel, By Country
- 3.3. Opportunities – By Treatment, By Drug Type, By End-User, By Distribution Channel, By Country
- 3.4. Trends – By Treatment, By Drug Type, By End-User, By Distribution Channel, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Chronic Kidney Disease Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Dialysis
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Kidney Transplant
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.3 Drug Therapy
- 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 ACE Inhibitors
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Angiotensin Receptor Blockers
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Diuretics
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.4 Phosphate Binders
- 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Dialysis Centers
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Clinics
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Hospital Pharmacies
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Retail Pharmacies
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 Online Pharmacies
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 North America
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 Europe
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Asia-Pacific
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.4 Latin America
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.5 Middle East & Africa
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.6 Global Chronic Kidney Disease Market - Opportunity Analysis Index, By Treatment, By Drug Type, By End-User, By Distribution Channel, and Region, 2024 - 2031
- 10.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Dialysis
- 10.1.2 Kidney Transplant
- 10.1.3 Drug Therapy
- 10.2.1 ACE Inhibitors
- 10.2.2 Angiotensin Receptor Blockers
- 10.2.3 Diuretics
- 10.2.4 Phosphate Binders
- 10.3.1 Hospitals
- 10.3.2 Dialysis Centers
- 10.3.3 Clinics
- 10.4.1 Hospital Pharmacies
- 10.4.2 Retail Pharmacies
- 10.4.3 Online Pharmacies
- 10.5.1 United States
- 10.5.2 Canada
10.7 Regional Trends Analysis
10.8 North America Global Chronic Kidney Disease Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
- 10.8.2 Company 2 (Canada)
- 10.8.3 Company 3 (Canada)
- 11.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Dialysis
- 11.1.2 Kidney Transplant
- 11.1.3 Drug Therapy
- 11.2.1 ACE Inhibitors
- 11.2.2 Angiotensin Receptor Blockers
- 11.2.3 Diuretics
- 11.2.4 Phosphate Binders
- 11.3.1 Hospitals
- 11.3.2 Dialysis Centers
- 11.3.3 Clinics
- 11.4.1 Hospital Pharmacies
- 11.4.2 Retail Pharmacies
- 11.4.3 Online Pharmacies
- 11.5.1 Germany
- 11.5.2 United Kingdom
- 11.5.3 France
- 11.5.4 Spain
- 11.5.5 Italy
- 11.5.6 Russia
- 11.5.7 Netherlands
- 11.5.8 Poland
- 11.5.9 Rest of Europe
11.7 Regional Trends Analysis
11.8 Europe Global Chronic Kidney Disease Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
- 11.8.2 Company 2 (United Kingdom)
- 11.8.3 Company 3 (United Kingdom)
- 12.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Dialysis
- 12.1.2 Kidney Transplant
- 12.1.3 Drug Therapy
- 12.2.1 ACE Inhibitors
- 12.2.2 Angiotensin Receptor Blockers
- 12.2.3 Diuretics
- 12.2.4 Phosphate Binders
- 12.3.1 Hospitals
- 12.3.2 Dialysis Centers
- 12.3.3 Clinics
- 12.4.1 Hospital Pharmacies
- 12.4.2 Retail Pharmacies
- 12.4.3 Online Pharmacies
- 12.5.1 China
- 12.5.2 Japan
- 12.5.3 India
- 12.5.4 South Korea
- 12.5.5 Australia & NZ
- 12.5.6 ASEAN
- 12.5.7 Rest of Asia-Pacific
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Chronic Kidney Disease Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
- 12.8.2 Company 2 (Japan)
- 12.8.3 Company 3 (Japan)
- 13.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Dialysis
- 13.1.2 Kidney Transplant
- 13.1.3 Drug Therapy
- 13.2.1 ACE Inhibitors
- 13.2.2 Angiotensin Receptor Blockers
- 13.2.3 Diuretics
- 13.2.4 Phosphate Binders
- 13.3.1 Hospitals
- 13.3.2 Dialysis Centers
- 13.3.3 Clinics
- 13.4.1 Hospital Pharmacies
- 13.4.2 Retail Pharmacies
- 13.4.3 Online Pharmacies
- 13.5.1 Brazil
- 13.5.2 Mexico
- 13.5.3 Argentina
- 13.5.4 Peru
- 13.5.5 Colombia
- 13.5.6 Rest of Latin America
13.7 Regional Trends Analysis
13.8 Latin America Global Chronic Kidney Disease Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
- 13.8.2 Company 2 (Mexico)
- 13.8.3 Company 3 (Mexico)
- 14.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 Dialysis
- 14.1.2 Kidney Transplant
- 14.1.3 Drug Therapy
- 14.2.1 ACE Inhibitors
- 14.2.2 Angiotensin Receptor Blockers
- 14.2.3 Diuretics
- 14.2.4 Phosphate Binders
- 14.3.1 Hospitals
- 14.3.2 Dialysis Centers
- 14.3.3 Clinics
- 14.4.1 Hospital Pharmacies
- 14.4.2 Retail Pharmacies
- 14.4.3 Online Pharmacies
- 14.5.1 Saudi Arabia
- 14.5.2 UAE
- 14.5.3 South Africa
- 14.5.4 Egypt
- 14.5.5 Israel
- 14.5.6 Rest of Middle East and Africa
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Chronic Kidney Disease Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
- 14.8.2 Company 2 (UAE)
- 14.8.3 Company 3 (UAE)
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 AstraZeneca
- 15.2.2 Bayer
- 15.2.3 Boehringer Ingelheim
- 15.2.4 Johnson & Johnson
- 15.2.5 GSK
- 15.2.6 Novartis
- 15.2.7 Fresenius Medical Care
- 15.2.8 Baxter
17. Principal Presumptions and Acronyms